共 50 条
- [31] The association of HLA-DQA1*05 carriage with immunogenicity to anti-tumour necrosis factor therapy and drug persistence in Asian patients with inflammatory bowel disease JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1635 - I1636
- [33] Impact of HLA-DQA1*05 Genotype in Immunogenicity and Failure to Treatment with Tumour Necrosis Factor-alpha Antagonists in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis JOURNAL OF CROHNS & COLITIS, 2024, 18 (07): : 1034 - 1052
- [34] Carriage of HLA-DQA1*05 in Hispanic IBD Patients Is Common and Also Associated With Development of Antibodies to Anti-TNFs but Not Other Biologics AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S369 - S370
- [35] Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to infliximab in patients with inflammatory bowel disease JOURNAL OF CROHNS & COLITIS, 2019, 13 : S435 - S436
- [36] Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to adalimumab in patients with Crohn's disease JOURNAL OF CROHNS & COLITIS, 2020, 14 : S574 - S574
- [38] Safety of anti-TNF treatment in older IBD patients: a systematic review and meta-analysis JOURNAL OF CROHNS & COLITIS, 2017, 11 : S248 - S248
- [39] The Oxford Anti-TNF Study of Immunogenicity and Sustained Response (OASIS-IBD): Analysis of 40,000 Patient Years of Anti-TNF Use JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1275 - I1277